AFYA Quote, Financials, Valuation and Earnings

BRF SA has a net margin of 17.66% compared to Afya's net margin of 4.95%. Afya's return on equity of 16% beat BRF SA's return on equity of 20.3%.

Afya has a consensus price target of $19.56, signalling upside risk potential of 0.82%. On the other hand BRF SA has an analysts' consensus of $4.99 which suggests that it could grow by 38.93%. Given that BRF SA has higher upside potential than Afya, analysts believe BRF SA is more attractive than Afya.

Afya has a beta of 0.599, which suggesting that the stock is 40.14% less volatile than S&P 500. In comparison BRF SA has a beta of 1.443, suggesting its more volatile than the S&P 500 by 44.257%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.2%. BRF SA offers a yield of 3.26% to investors and pays a quarterly dividend of $0.02 per share. Afya pays -- of its earnings as a dividend. BRF SA pays out 35.62% of its earnings as a dividend. BRF SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Afya quarterly revenues are $145.3M, which are smaller than BRF SA quarterly revenues of $3B. Afya's net income of $25.7M is lower than BRF SA's net income of $148.6M. Notably, Afya's price-to-earnings ratio is 14.91x while BRF SA's PE ratio is 9.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.92x versus 0.52x for BRF SA. Usually stocks with elevated PS ratios are considered overvalued.

Brasilagro - Cia Bras de Prop Agricolas has a net margin of 17.66% compared to Afya's net margin of -12.82%. Afya's return on equity of 16% beat Brasilagro - Cia Bras de Prop Agricolas's return on equity of 13.42%.

Afya has a consensus price target of $19.56, signalling upside risk potential of 0.82%. On the other hand Brasilagro - Cia Bras de Prop Agricolas has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya has higher upside potential than Brasilagro - Cia Bras de Prop Agricolas, analysts believe Afya is more attractive than Brasilagro - Cia Bras de Prop Agricolas.

Afya has a beta of 0.599, which suggesting that the stock is 40.14% less volatile than S&P 500. In comparison Brasilagro - Cia Bras de Prop Agricolas has a beta of 0.496, suggesting its less volatile than the S&P 500 by 50.386%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.2%. Brasilagro - Cia Bras de Prop Agricolas offers a yield of 7.4% to investors and pays a quarterly dividend of $0.27 per share. Afya pays -- of its earnings as a dividend. Brasilagro - Cia Bras de Prop Agricolas pays out 140.63% of its earnings as a dividend.

Afya quarterly revenues are $145.3M, which are larger than Brasilagro - Cia Bras de Prop Agricolas quarterly revenues of $26.2M. Afya's net income of $25.7M is higher than Brasilagro - Cia Bras de Prop Agricolas's net income of -$3.4M. Notably, Afya's price-to-earnings ratio is 14.91x while Brasilagro - Cia Bras de Prop Agricolas's PE ratio is 7.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.92x versus 1.66x for Brasilagro - Cia Bras de Prop Agricolas. Usually stocks with elevated PS ratios are considered overvalued.

Minerva SA has a net margin of 17.66% compared to Afya's net margin of -14.3%. Afya's return on equity of 16% beat Minerva SA's return on equity of -186.61%.

Afya has a consensus price target of $19.56, signalling upside risk potential of 0.82%. On the other hand Minerva SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya has higher upside potential than Minerva SA, analysts believe Afya is more attractive than Minerva SA.

Afya has a beta of 0.599, which suggesting that the stock is 40.14% less volatile than S&P 500. In comparison Minerva SA has a beta of -0.247, suggesting its less volatile than the S&P 500 by 124.744%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.2%. Minerva SA offers a yield of 0% to investors and pays a quarterly dividend of $0.16 per share. Afya pays -- of its earnings as a dividend. Minerva SA pays out -- of its earnings as a dividend.

Afya quarterly revenues are $145.3M, which are smaller than Minerva SA quarterly revenues of $1.8B. Afya's net income of $25.7M is higher than Minerva SA's net income of -$262.3M. Notably, Afya's price-to-earnings ratio is 14.91x while Minerva SA's PE ratio is 57.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.92x versus 0.12x for Minerva SA. Usually stocks with elevated PS ratios are considered overvalued.

Vasta Platform has a net margin of 17.66% compared to Afya's net margin of 86.92%. Afya's return on equity of 16% beat Vasta Platform's return on equity of 9.62%.

Afya has a consensus price target of $19.56, signalling upside risk potential of 0.82%. On the other hand Vasta Platform has an analysts' consensus of $3.13 which suggests that it could fall by -27.36%. Given that Afya has higher upside potential than Vasta Platform, analysts believe Afya is more attractive than Vasta Platform.

Afya has a beta of 0.599, which suggesting that the stock is 40.14% less volatile than S&P 500. In comparison Vasta Platform has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.2%. Vasta Platform offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Afya pays -- of its earnings as a dividend. Vasta Platform pays out -- of its earnings as a dividend.

Afya quarterly revenues are $145.3M, which are larger than Vasta Platform quarterly revenues of $119.6M. Afya's net income of $25.7M is lower than Vasta Platform's net income of $104M. Notably, Afya's price-to-earnings ratio is 14.91x while Vasta Platform's PE ratio is 4.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.92x versus 1.12x for Vasta Platform. Usually stocks with elevated PS ratios are considered overvalued.